科华生物涨2.03%，成交额1983.77万元，主力资金净流出56.55万元

Core Insights - Kewah Bio's stock price increased by 2.03% on October 31, reaching 6.54 CNY per share, with a market capitalization of 3.364 billion CNY [1] - The company reported a revenue of 1.191 billion CNY for the first nine months of 2025, a year-on-year decrease of 11.77%, and a net profit of -233 million CNY, down 90.38% year-on-year [2] Financial Performance - Year-to-date stock price change is an increase of 3.65%, with a recent decline of 0.61% over the last five trading days [1] - The company has cumulatively distributed 1.694 billion CNY in dividends since its A-share listing, with 309 million CNY distributed in the last three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 13.91% to 48,100, while the average number of circulating shares per person decreased by 12.21% to 10,689 shares [2] - The sixth largest circulating shareholder is the Medical Device ETF (159883), which holds 3.1732 million shares as a new entrant [3]